The Targeted Therapeutic Drug Discovery & Development Program (TTP) is funded by a CPRIT Core Facilities Support Award (grant # RP160657) and provides researchers with access to cutting-edge technologies and expertise to enable the translation of their research into new treatments for cancers. The goal of TTP is focused on assisting cancer scientists and clinicians by utilizing a truly integrated approach of targeted molecular drug discovery, uniting every key discipline to achieve their goals in a single platform. We believe that having such an integrated platform (Figure) will increase the number of new compounds in Texas reaching the stage of pre-clinical testing that possess the potency, selectivity and pharmacokinetic parameters needed to engage and inhibit oncogenic targets in tumors.
- Instrument Reservation
- Contact Us